Rapid weight loss and reduced appetite can put key nutrients at risk, which has implications for both patient safety and clinical trial outcomes
Anti-emetic medications may be considered in some cases, though lifestyle modifications are typically the first-line approach
1 2 3 "Generic Ozempic is now on Canadian shelves
This article explains what biomarkers can optionally be monitored on GLP-1 therapy and why, who might benefit from testing versus who likely does not need it, what baseline and ongoing monitoring might involve if you choose to do it, and how to decide what makes sense for your situation
Firms are increasing investments in new oral formulations of the drug, better therapy, and increased production to ensure greater availability of treatments in the future
Semaglutide's 168-hour half-life delivers near-constant receptor activation, meaning appetite suppression is steady throughout the entire week